Lower and Upper Gastrointestinal Symptoms Differ Between Individuals With Irritable Bowel Syndrome With Constipation or Chronic Idiopathic Constipation
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
Background/AimsWe evaluated the distribution of lower and upper gastrointestinal (GI) symptoms among individuals with irritable bowel syndrome with constipation (IBS-C) and chronic idiopathic constipation (CIC) in a nationwide survey. Methods Individuals(≥ 18 years of age) were identified from a nationwide sample of > 70 000 United States adults.Participants completed the National Institutes of Health GI Patient Reported Outcomes Measurement Information System (NIH GI-PROMIS) questionnaire.Symptom frequency and intensity in the prior 7 days were assessed using validated PROMIS scores.Odds ratios (OR) with 95% confidence intervals (CI) were calculated to compare symptom prevalence in IBS-C vs CIC, and one-way ANOVA was used to assess differences in PROMIS scores.Regression analysis was performed to adjust for demographic variables. ResultsNine hundred and seventy adults met eligibility criteria (275 with IBS-C, 734 with CIC).Demographics were similar among groups except for education, marital and employment status, and income.Adjusting for demographic differences, GI-PROMIS scores of global GI symptoms were higher in IBS-C (251.1;95% CI, 230.0-273.1)compared to CIC (177.8;95% CI 167.2-188.4)(P < 0.001).Abdominal pain was more prevalent (OR, 4.3; 95% CI, 2.9-6.6) and more severe (P = 0.007) in IBS-C.Constipation was more severe in IBS-C (P = 0.011).Incontinence was more common (OR, 2.9; 95% CI, 1.3-6.3)but just as severe (P = 0.389) in IBS-C versus CIC.Regarding upper GI symptoms, the prevalence of dysphagia, heartburn, and nausea were similar.However, IBS-C individuals had more severe heartburn (P = 0.001). ConclusionGI symptoms are generally more severe in IBS-C compared to CIC, however abdominal pain, bloating, and upper GI symptoms still commonly occur in CIC. (
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The 290 μg daily dose is approved for IBS-C, recognizing that CIC and IBS-C overlap and are often indistinguishable in practice. 66”
From American Gastroenterological Association-American College of Gastroenterology Clinical Practice Guideline: Pharmacological Management of Chronic Idiopathic Constipation (2023) · cites this paper as [66]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cella, D., Yount, S., Rothrock, N., Gershon, R., Cook, K., Reeve, B., Ader, D., Fries, J. F., Bruce, B., & Rose, M. (2007) · Medical Care · doi:10.1097/01.mlr.0000258615.42478.55 · Cited by 3,118
Shekhar, C., Monaghan, P. J., Morris, J., Issa, B., Whorwell, P. J., Keevil, B. G., & Houghton, L. A. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.07.014 · Cited by 2,927 · cited 1×
“In a study evaluating platelet-depleted plasma serotonin levels in subjects with IBS-C or CIC, prior authors reported platelet-depleted plasma serotonin levels varying with pain and stool thresholds, but that both IBS-C and CIC appeared to have similar characteristic symptom and physiologic overlap.(23) The prevalence…”
Lacy, B. E., Mearin, F., Chang, L., Chey, W. D., Lembo, A. J., Simren, M., & Spiller, R. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.02.031 · Cited by 2,866
Self-citation(2013) · Gastroenterology Research · doi:10.1053/j · Cited by 2,759
Burden of Gastrointestinal Disease in the United States: 2012 Update
Peery, A. F., Dellon, E. S., Lund, J., Crockett, S. D., McGowan, C. E., Bulsiewicz, W. J., Gangarosa, L. M., Thiny, M. T., Stizenberg, K., Morgan, D. R., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.08.002 · Cited by 2,015 · cited 1×
“Constipation is amongst the most common gastrointestinal (GI) complaints reported by individuals seeking advice from a health care provider.(1) Up to 20% of the United States (US) adult population suffers with some form of constipation.”
Epidemiology of Constipation in North America: A Systematic Review
Higgins, P. D., & Johanson, J. F. (2004) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2004.04114.x · Cited by 1,080 · cited 1×
“One potential limitation of this study was the low prevalence of IBS-C and CIC in our survey population, even lower than the prevalence reported in other cross-sectional surveys(3,6,11) and systematic reviews.(28,29) The primary reason for this is likely our use of the validated GI-PROMIS system, which assesses sympto…”
The epidemiology of irritable bowel syndrome
Card, T., Canavan, C., & West, J. (2014) · Clinical Epidemiology · doi:10.2147/clep.s40245 · Cited by 889 · cited 1×
“One potential limitation of this study was the low prevalence of IBS-C and CIC in our survey population, even lower than the prevalence reported in other cross-sectional surveys(3,6,11) and systematic reviews.(28,29) The primary reason for this is likely our use of the validated GI-PROMIS system, which assesses sympto…”
Development and Validation of the Rome IV Diagnostic Questionnaire for Adults
Palsson, O. S., Whitehead, W. E., van Tilburg, M. A. L., Chang, L., Chey, W., Crowell, M. D., Keefer, L., Lembo, A. J., Parkman, H. P., Rao, S. S. C., et al. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.02.014 · Cited by 719
Self-citationChronic constipation: a survey of the patient perspective
JOHANSON, J. F., & KRALSTEIN, J. (2007) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.03238.x · Cited by 617 · cited 2×
“Insufficiencies in our understanding of the overall symptom complex of these disorders might contribute to the high rates of patient dissatisfaction with treatment for IBS-C and CIC patients.(4) Characteristic bowel symptoms and some abdominal symptoms have been evaluated in the literature in a comparative manner betw…”
Halder, S. L. S., Locke, G. R., Schleck, C. D., Zinsmeister, A. R., Melton, L. J., & Talley, N. J. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.06.010 · Cited by 311
Research works printed but not linked: 1
- 10.1111/j.1572-0241.2000.02075.x · doi:10.1111/j.1572-0241.2000.02075.x · Paper page
Cited by
Prevalence of Gastroesophageal Reflux Disease and Proton Pump Inhibitor-Refractory Symptoms
Delshad, S. D., Almario, C. V., Chey, W. D., & Spiegel, B. M. R. (2020) · Gastroenterology · doi:10.1053/j.gastro.2019.12.014 · Cited by 252
Self-citationChang, L., Chey, W. D., Imdad, A., Almario, C. V., Bharucha, A. E., Diem, S., Greer, K. B., Hanson, B., Harris, L. A., Ko, C., et al. (2023) · Gastroenterology · doi:10.1053/j.gastro.2023.03.214 · Cited by 185
Self-citationAlmario, C. V., Ballal, M. L., Chey, W. D., Nordstrom, C., Khanna, D., & Spiegel, B. M. R. (2018) · American Journal of Gastroenterology · doi:10.1038/s41395-018-0256-8 · Cited by 176
Self-citationChang, L., Chey, W. D., Imdad, A., Almario, C. V., Bharucha, A. E., Diem, S. J., Greer, K. B., Hanson, B., Harris, L. A., Ko, C. W., et al. (2023) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000002227 · Cited by 56
“The 290 mg daily dose is approved for IBS-C, recognizing that CIC and IBS-C overlap and are often indistinguishable in practice (66).”
BackgroundSelf-citationBurden of Constipation: Looking Beyond Bowel Movements
Harris, L. A., & Chang, C. H. (2022) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000001708 · Cited by 38
Metadata
- Authors
- Shah, E. D., Almario, C. V., Spiegel, B. M. R., & Chey, W. D.
- Affiliations
- University of Michigan (US)
- Cedars-Sinai Medical Center (US)
- Corresponding author
- Chey, William D
- Venue
- Journal of Neurogastroenterology and Motility
- Published
- 2018-04-30
- Volume
- 24
- Issue
- 2
- Pages
- 299-306
- ISSN
- 2093-0879 (ISSN-L)
- 2093-0887
- PMC
- PMC5885729
- OpenAlex
- W2795842494
- Cited by
- 27
- References
- 31
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 2 · 2023: 6 · 2022: 3 · 2021: 1 · 2020: 6 · 2019: 2 · 2018: 3
- FWCI
- 2.86
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Licence
- cc-by-nc
- Locations
- Journal of Neurogastroenterology and Motility (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Funders
- Ironwood Pharmaceuticals, Incorporated
- Topics
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Health Sciences › Medicine › Urology › Pelvic floor disorders treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Keywords
- irritable bowel syndrome with constipation, chronic idiopathic constipation, gastrointestinal symptoms, abdominal pain, bloating, heartburn, dysphagia, fecal incontinence, symptom severity, upper gastrointestinal symptoms, lower gastrointestinal symptoms
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Lower and Upper Gastrointestinal Symptoms Differ Between Individuals With Irritable Bowel Syndrome With Constipation or Chronic Idiopathic Constipation. https://app.cochat.ai/papers/10.5056/jnm17112
- The paper
- Shah, E. D., Almario, C. V., Spiegel, B. M. R., & Chey, W. D. (2018). Lower and Upper Gastrointestinal Symptoms Differ Between Individuals With Irritable Bowel Syndrome With Constipation or Chronic Idiopathic Constipation. Journal of Neurogastroenterology and Motility. https://doi.org/10.5056/jnm17112
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.